Visceral Fat in Men After 50

Men often carry more fat around the middle, and after 50 that change can become easier to notice. If you’re looking into visceral fat in men after 50, the term means fat inside the abdominal cavity around internal organs. A tape measure cannot directly quantify it, but waist measures can add useful information that weight or body mass index (BMI), a measure of weight relative to height, misses. At Humanic Blue, we treat that measurement as one clue, not a diagnosis.

The important distinction is between a useful signal and a verdict. A UK Biobank study linked higher waist-to-hip ratios with higher death rates even after accounting for other measured factors. It did not establish that the ratio is a better clinical test or that shrinking it extends life. The National Heart, Lung, and Blood Institute (NHLBI) identifies a waist above 40 inches in men as one marker of increased heart-disease and type 2 diabetes risk. Exercise trials in adults with overweight or obesity found reductions in visceral fat. For living longer and better, these findings concern risk assessment and body composition; they do not establish a lifespan benefit from reducing one measurement.

Which number says something useful about visceral fat?

In the UK Biobank analysis, all measured indicators of body fat were positively associated with new chronic diseases. After the investigators’ full adjustment, however, only waist-to-hip ratio retained a positive association with death. Among men, those near the high end of the waist-to-hip range had a 19% higher relative risk of death than those near the low end. That is a comparison between groups, not a prediction of what would happen if one man changed his ratio. BMI and bioimpedance body-fat percentage—estimated from how an electrical signal travels through the body—were associated with lower rather than higher mortality after adjustment. Such results can be affected by unmeasured differences between people or illness-related weight loss; they do not establish that more body fat is protective. Most participants were White, and body measurements were taken only at the start.

How to measure. Waist circumference is the simpler check. The NHLBI uses more than 40 inches for men as a level associated with increased heart-disease and type 2 diabetes risk. Waist-to-hip ratio divides waist circumference by hip circumference. Results depend on where and how the tape is placed, and neither measure directly images visceral fat. Threshold performance also varies across populations, so the number belongs inside a broader clinical risk assessment.

What does visceral fat predict—and what can’t it prove?

In a 2026 study of whole-body MRI scans from adults in the UK Biobank and German National Cohort, researchers compared visceral-fat amounts with reference values for age, sex and height. The high-fat category had up to 2.26 times the risk of developing diabetes compared with the middle category after accounting for traditional risk factors. The outcome analysis came from the UK Biobank portion, and the observational design cannot show that lowering MRI-measured fat would reduce diabetes risk. Low skeletal muscle showed the strongest body-composition association with death in the final analysis. Why muscle matters is covered in Muscle Loss in Men After 50.

An older Framingham Heart Study analysis also found that CT-measured visceral fat was more closely associated with lower adiponectin, a blood marker related to metabolism, than fat under the skin was. The study compared measurements at one point in time. It did not establish how visceral fat affects disease, or show a benefit that patients would notice.

What would distinguish visceral fat as a predictor from visceral fat as a cause of disease?

The testosterone question

Low testosterone and excess abdominal fat often go together, and observational research links weight gain to testosterone declines, as covered in Testosterone and Aging. In a 2016 meta-analysis of 59 randomized trials, testosterone supplementation reduced fat mass and increased fat-free mass (tissue other than fat) on average but did not significantly change body weight, waist circumference or BMI. The trials varied in population, formulation and duration, and body-composition changes do not establish fewer cardiovascular events, diabetes cases or deaths.

The American College of Physicians advises against starting testosterone to improve energy, vitality or physical function in men with age-related low testosterone, as covered in Testosterone Therapy and Healthy Aging.

Which outcomes beyond a scan would be needed to assess a testosterone-related change in visceral fat?

What has reduced visceral fat in trials?

Aerobic exercise. A 2024 dose-response meta-analysis pooled randomized trials in adults with overweight or obesity. As weekly moderate-to-vigorous aerobic exercise increased toward 300 minutes, body weight, waist circumference and fat measures generally declined. The analysis included studies measuring visceral-fat area on scans. The relationship between weekly exercise time and average changes is detailed below. This is a group average across adults, not a men-over-50 prescription or proof of longer life.

GLP-1-based medications. These prescription drugs act on the glucagon-like peptide-1 pathway, which helps regulate appetite and blood sugar. A 2026 meta-analysis found reductions in weight, fat mass and visceral adipose tissue in adults with overweight or obesity, with or without type 2 diabetes. The included drugs, populations and body-composition methods varied, and lean mass—muscle and other tissue that is not fat—also declined. These are prescription treatments with product-specific indications, contraindications and adverse effects—not visceral-fat supplements or a reason to treat a tape measurement alone.

Strength training. Resistance training concerns preserving muscle and strength. Low muscle carried the strongest mortality association in the MRI study, but that does not establish that strength training reduces deaths. See Strength Training for Longevity.